Market icon

Which vaccines will RFK end recommendations for?

$1,282,583 Vol.

OUTCOME

% CHANCE

Rules

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volume
$1,282,583
End Date
Dec 31, 2025
Created At
Feb 22, 2025, 12:10 AM
shield

Beware of external links.

$1,282,583 Vol.

Market icon

Which vaccines will RFK end recommendations for?

OUTCOME

% CHANCE

Measles Mumps and Rubella

$257,968 Vol.

5%

COVID-19

$561,730 Vol.

4%

Hepatitis B

$123,925 Vol.

4%

Influenza

$21,837 Vol.

4%

HPV

$304,864 Vol.

4%

Polio

$12,258 Vol.

1%

About

Volume
$1,282,583
End Date
Dec 31, 2025
Created At
Feb 22, 2025, 12:10 AM